查詢結果分析
來源資料
頁籤選單縮合
題 名 | Squamous Cell Carcinoma of the Anal Canal: Radical and Palliative Treatments and Prognosis=肛管鱗狀細胞癌:姑息性和根治性治療及預後 |
---|---|
作 者 | 魏達成; 魏柏立; 游憲章; 許書劍; | 書刊名 | 中華民國外科醫學會雜誌 |
卷 期 | 29:4 民85.07-08 |
頁 次 | 頁320-324 |
分類號 | 416.245 |
關鍵詞 | 肛管鱗狀細胞癌; Squamous cell carcinoma; Anal canal; Chemoradiotherapy; Surgery; |
語 文 | 英文(English) |
中文摘要 | 從1978年到1992年,有20病例的肛管鱗狀細胞癌經多形方式治療。病人 的追蹤時間從.SO到142個月,平均為87個月。最初常見的手術方式為寬廣的局部 切除術(I2病例中的8例:-67),有一個病人保留了肛門的自制,另有11病例需要做 腹會陰切除術。經過根治性治療的12病例約五年生存率為75,而全部20病例約五 年生存率為45。沒有與治療有關的死亡。因此病人須經放射線治療或化學治療為 治療這種肛管癌的主要方式,若失敗或復發,再經外科治療才能夠控局部的疾病。 |
英文摘要 | From January 1978 to December 1992, 20 patients with squamous cell carcinoma of the anal canal were treated here; 12 patients received radicaltreatment using a multimodality approach and eight patients, palliativetreatment. Follow-up times of the patients ranged from 30 to 142 months,with a mean follow-up time of 87 months. For radical treatment, 8 (67) of12 patients had wide local excision initially. One patient retained anal continence and II patients required abdominoperineal resection. The overallfive-year survival rate after wide local excision or abdominoperineal resection was 75. There were no treatment-related deaths. Preoperative tumorsize was the factor most significantly related to survival. Patients shouldbe treated with chemoradiotherapy; if the treatment fails or the tumorrecurs, surgical therapy is used to control local disease. Of those withpalliative treatment, all 8 patients died of bilateral hepatic metastasesbetween 3 to 35 months. |
本系統中英文摘要資訊取自各篇刊載內容。